Testing effectiveness (Phase 2)Study completedNCT02350530
What this trial is testing
FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type
Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 138